(2-{4-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-oxoethyl)-N-methylcarbamic acid tert-butyl ester → HCID 69635723, 화합물

HRID 25225

반응식

HRID 25225 반응식
C(O[C:6](=O)[N:7]([CH2:9][C:10]([N:12]1[CH2:17][CH2:16][N:15]([C:18]2[CH:23]=[CH:22][CH:21]=[C:20]([CH2:24][S:25]([CH:28]=[C:29]3[CH2:32][N:31]([CH:33]([C:41]4[CH:46]=[CH:45][C:44]([Cl:47])=[CH:43][CH:42]=4)[C:34]4[CH:39]=[CH:38][C:37]([Cl:40])=[CH:36][CH:35]=4)[CH2:30]3)(=[O:27])=[O:26])[CH:19]=2)[CH2:14][CH2:13]1)=[O:11])C)(C)(C)C>C(O)=O>[Cl:40][C:37]1[CH:36]=[CH:35][C:34]([CH:33]([C:41]2[CH:42]=[CH:43][C:44]([Cl:47])=[CH:45][CH:46]=2)[N:31]2[CH2:30][C:29](=[CH:28][S:25]([CH2:24][C:20]3[CH:19]=[C:18]([N:15]4[CH2:14][CH2:13][N:12]([C:10](=[O:11])[CH2:9][NH:7][CH3:6])[CH2:17][CH2:16]4)[CH:23]=[CH:22][CH:21]=3)(=[O:27])=[O:26])[CH2:32]2)=[CH:39][CH:38]=1

참가 물질

3

반응물 1

HCID 69635644(2-{4-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-oxoethyl)-N-methylcarbamic acid tert-butyl ester

생성물 1

HCID 69635723HCID 69635723, 화합물수율 83.3%

시약·촉매·용매 1

HCID 284Formic Acid용매

실험 절차

A solution of 81 mg of (2-{4-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-oxoethyl)-N-methylcarbamic acid tert-butyl ester in 2.5 cm3 of formic acid is stirred for 1 hour at a temperature close to 45° C. The reaction mixture is concentrated to dryness under reduced pressure (5 kPa) at a temperature close to 30° C., taken up in 10 cm3 of ethyl acetate and alkalinized with 10 cm3 of a saturated aqueous sodium bicarbonate solution. After separating after settling out, the organic phase is washed with 10 cm3 of water, dried over magnesium sulfate, filtered and concentrated to dryness under reduced pressure (1 kPa) at a temperature close to 40° C. 58 mg of 1-{4-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-methylaminoethanone are thus obtained in the form of a beige lacquer [1H NMR spectrum (300 MHz, CDCl3), δ in ppm): from 1.95 to 2.15 (broad unresolved complex, 1H), 2.51 (broad s, 3H), 2.77 (s, 3H), from 3.10 to 3.30 (mt, 4H), 3.49 (broad s, 2H), 3.58 (mt, 2H), from 3.75 to 3.90 (mt, 4H), 4.33 (mt, 2H), 4.49 (s, 1H), 6.83 (broad d, J=8 Hz, 1H), 6.90 (dd, J=8 and 2 Hz, 1H), 7.00 (mt, 1H), from 7.20 to 7.40 (mt, 9H)].

후처리

  1. customclose to 45° C
  2. concentrationThe reaction mixture is concentrated to dryness under reduced pressure (5 kPa) at a temperature
  3. customclose to 30° C.
  4. customAfter separating
  5. washthe organic phase is washed with 10 cm3 of water
  6. dry with materialdried over magnesium sulfate
  7. filtrationfiltered
  8. concentrationconcentrated to dryness under reduced pressure (1 kPa) at a temperature
  9. customclose to 40° C

출처 및 근거

ORD 기록
ord-250ca74c6e324958a0bd02203acce9a1
출처 데이터셋
uspto-grants-2005_02
특허 번호
US06858603B2

연결된 노트

불러오는 중…